{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:05:13Z","timestamp":1777953913609,"version":"3.51.4"},"reference-count":13,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,4,21]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to assess whether single-agent pharmacotherapy directed at the patient-prioritised, highest-scoring PERSONS symptom (target symptom) produces concurrent improvements in both the target symptom and overall symptom burden in advanced-cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Consecutive adults receiving palliative care specialist between April\u202f2023 and February\u202f2024 were enrolled if \u22651 PERSONS item scored\u202f\u2265\u202f7\/10. At baseline (T\n                      <jats:sub>0<\/jats:sub>\n                      ), clinicians identified the target symptom and initiated one guideline-concordant drug for its control. Follow-up (T\n                      <jats:sub>1<\/jats:sub>\n                      ) occurred after 14 days (median). Outcomes were change in target-symptom severity and change in total PERSONS score. Paired t-tests compared T\n                      <jats:sub>0<\/jats:sub>\n                      and T\n                      <jats:sub>1<\/jats:sub>\n                      ; Pearson\u2019s r examined correlations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      81 patients (median age 71years; 55.6% female; 81.5% metastatic disease) completed both assessments. Target-symptom severity fell from 7.63\u202f\u00b1\u202f1.02\u2009to 3.78\u202f\u00b1\u202f1.35 (mean reduction 3.85\u202fpoints; 95%\u202fCI 3.45 to 4.25; p&lt;0.0001). The total PERSONS score decreased from 21.94\u202f\u00b1\u202f4.56\u2009to 13.46\u202f\u00b1\u202f5.12 (mean reduction\u202f8.48\u202fpoints; 95%\u202fCI 7.54 to 9.42; p&lt;0.0001). Target-symptom severity correlated moderately with non-target PERSONS score at T\n                      <jats:sub>0<\/jats:sub>\n                      (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.55) and strongly at T\n                      <jats:sub>1<\/jats:sub>\n                      (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.65; both p&lt;0.0001). Pain was the predominant target symptom (45.7\u202f%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Focusing on a single, evidence-based drug on the patient-defined dominant symptom halved target-symptom intensity and reduced global symptom burden by 39% within 2\u2009weeks. These findings support a pragmatic \u2018less-is-more\u2019 paradigm that may minimise polypharmacy while delivering broad symptomatic benefit in advanced cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2026-006159","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:20:12Z","timestamp":1777915212000},"page":"spcare-2026-006159","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Target symptom-guided prescribing in home-based specialist palliative care: prospective quality improvement study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4592-8868","authenticated-orcid":false,"given":"Raffaele","family":"Giusti","sequence":"first","affiliation":[{"name":"Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant\u2019Andrea, Rome, Lazio, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-363X","authenticated-orcid":false,"given":"Daniele","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology 2, IRCSS Regina Elena National Cancer Institute, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guglielmo","family":"Fumi","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera S. Maria S.C. Oncologia, Terni, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Toccaceli","sequence":"additional","affiliation":[{"name":"Hospice Care Unit, USL Umbria, Perugia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Ravoni","sequence":"additional","affiliation":[{"name":"Tuscany Tumors Association Home Care Service, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Colpani","sequence":"additional","affiliation":[{"name":"Tuscany Tumor Association Home Care Service, Florence, Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Vacca","sequence":"additional","affiliation":[{"name":"Unit of pain therapy and palliative care, Azienda Sanitaria Locale 7 Carbonia, Iglesias, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Fiorani","sequence":"additional","affiliation":[{"name":"Department of Oncology and Haematology, University Hospital of Modena, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Porzio","sequence":"additional","affiliation":[{"name":"Tuscany Tumors Association Home Care Service, Florence, Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-7161","authenticated-orcid":false,"given":"Maria Anna","family":"Siciliano","sequence":"additional","affiliation":[{"name":"Oncology Department, Azienda Ospedaliero Universitaria Renato Dulbecco di Catanzaro, Catanzaro, Calabria, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"2026050410200767000_spcare-2026-006159v1.1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28376"},{"key":"2026050410200767000_spcare-2026-006159v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2008.04.018"},{"key":"2026050410200767000_spcare-2026-006159v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.09.003"},{"key":"2026050410200767000_spcare-2026-006159v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.10.027"},{"key":"2026050410200767000_spcare-2026-006159v1.5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw253","article-title":"Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations","volume":"109","author":"Miaskowski","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"2026050410200767000_spcare-2026-006159v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7156"},{"key":"2026050410200767000_spcare-2026-006159v1.7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1478951519000543","article-title":"The PERSONS score: A new tool for cancer patients\u2019 symptom assessment in simultaneous care and home care settings","volume":"18","author":"Cortellini","year":"2020","journal-title":"Palliat Support Care"},{"key":"2026050410200767000_spcare-2026-006159v1.8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clbc.2013.02.014","article-title":"The validity and utility","volume":"13","author":"Mendoza","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"2026050410200767000_spcare-2026-006159v1.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.1474"},{"key":"2026050410200767000_spcare-2026-006159v1.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6933.896"},{"key":"2026050410200767000_spcare-2026-006159v1.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8881"},{"key":"2026050410200767000_spcare-2026-006159v1.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1408-9"},{"key":"2026050410200767000_spcare-2026-006159v1.13","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1634\/theoncologist.2019-0406","article-title":"Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis","volume":"25","author":"Mohamed","year":"2020","journal-title":"Oncologist"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2026-006159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:20:13Z","timestamp":1777915213000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2026-006159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":13,"alternative-id":["10.1136\/spcare-2026-006159"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2026-006159","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}